Adeptrix has developed a mass spectrometry-based, high-content and high-throughput microarray platform for screening changes. Founded in 2010, Adeptrix is backed by investors that include Bruker and is headquartered in Beverly.
FOUNDED:
2010
INDUSTRY:
Medical, Medical Device
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.